Hospira Japan Receives Approval for New Indication for 'Preced... - 23 August 2010 12:00

OSAKA, Japan, Aug. 23 /PRNewswire-AsiaNet/ -- ~ Also, First Approvals For Product for <24 Hour Sedation In Canada, South Korea ~ Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of...

  Daily Intake of "Yakult" Is Efficacious in Reducing Incidence ... - 20 August 2010 23:30

TOKYO, Aug. 20 /Kyodo JBN-AsiaNet/ -- -Collaborative Study with India National Institute of Cholera and Enteric Diseases- YAKULT HONSHA CO., LTD. announced on August 20 that its collaborative study on the incidence of acute diarrhea with the National Institute of Cholera and ...

  Daily Intake of "Yakult" Is Efficacious in Reducing Incidence ... - 20 August 2010 23:30

TOKYO, Aug. 20 /Kyodo JBN-AsiaNet/ -- -Collaborative Study with India National Institute of Cholera and Enteric Diseases- YAKULT HONSHA CO., LTD. announced on August 20 that its collaborative study on the incidence of acute diarrhea with the National Institute of Cholera and Enteri...

  Hospira Announces CEO Succession Plan - 20 August 2010 23:08

LAKE FOREST, Ill., Aug. 20 /PRNewswire-AsiaNet/ -- -- Chris Begley to retire as CEO and assume role as executive chairman; Board to initiate search for successor -- The board of directors of Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medicatio...

  Phase III Randomised Controlled Trial Confirms Clinical Effica... - 20 August 2010 07:30

BRUSSELS, Aug. 20 /PRNewswire-AsiaNet/ -- Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver me...

  Cyprotex Adds In Vitro Toxicology Services - 20 August 2010 07:15

MACCLESFIELD, England, Aug. 20 /PRNewswire-AsiaNet/ -- Cyprotex PLC (LSE:CRX), the preclinical ADME Tox services company, today announces the launch of its new in vitro toxicology service, branded as Cyprotox(R). Supporting the new service is an additional 90 square metres of laboratory space a...

  Ansell Strengthens Global Management Team With New Appointments - 20 August 2010 03:42

RED BANK, New Jersey and MELBOURNE, Australia, Aug. 20 /PRNewswire-AsiaNet/ -- Earlier today global leader in protection solutions, Ansell, announced two new appointments to its global executive leadership team. These appointments, both effective immediately and both reporting to the CEO, Magnus Nicolin, follow an ear...

  Multi-centre Phase II Trial Reports Safety and Clinical Benefi... - 20 August 2010 00:18

ROME, Aug 19/PRNewswire-AsiaNet/ -- Radioactive yttrium-90 labelled resin microspheres (SIR-Spheres; Sirtex Medical, Sydney, Australia) appear to be a safe and effective treatment for patients with colorectal cancer liver metastases who have failed available chemotherapy opti...

  Treatment with Elekta's Leksell Gamma Knife Perfexion Introduc... - 19 August 2010 23:00

SYDNEY and ATLANTA, Aug. 19 /PRNewswire-AsiaNet/ -- Macquarie University Hospital begins brain surgery with the continent's first intracranial radiosurgery system On August 3, Macquarie University Hospital (MUH) performed Australia's first Gamma Knife(R) surgery with i...

  Regenicin Completes Acquisition of Worldwide Exclusive Know-Ho... - 18 August 2010 21:37

NEW YORK, Aug. 18 /PRNewswire-AsiaNet/ -- Lonza to Provide Exclusive Manufacturing Services to Regenicin for new Proprietary Skin Production Technology Regenicin, Inc. (OTC Bulletin Board: WDSTD), a development stage biotechnology company, announced today ...